NCT05039411View on ClinicalTrials.gov

Safety of Allogeneic Human Umbilical Cord Mesenchymal Stem Cells (UC-MSCs) to Treat Perianal Fistulas w/ Crohn's Disease

PHASE1RecruitingINTERVENTIONAL
Enrollment

5

Participants

Timeline

Start Date

March 1, 2022

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2026

Conditions
Perianal Fistula Due to Crohn's DiseaseFistula in Ano
Interventions
BIOLOGICAL

PF2020-CELL (UC-MSCs) - Allogeneic Human Umbilical Cord Mesenchymal Stem Cells

All patients will receive a total of 60 million PF2020-CELL (UC-MSCs) cells per treatment visit.

Trial Locations (1)

59100

RECRUITING

University of Malaya Medical Centre, Kuala Lumpur

All Listed Sponsors
collaborator

University of Malaya

OTHER

lead

CryoCord Sdn Bhd

INDUSTRY